Enanta Pharmaceuticals Inc (ENTA):企業の財務・戦略的SWOT分析

◆英語タイトル:Enanta Pharmaceuticals Inc (ENTA) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C14976
◆発行会社(調査会社):GlobalData
◆発行日:2019年3月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD300 ⇒換算¥33,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD600 ⇒換算¥66,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥99,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Enanta Pharmaceuticals Inc (Enanta) is a biotechnology company that discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. The company’s lead product candidate includes EDP-305, a farnesoid X receptor (FXR) agonist intended for the treatment of non-alcoholic steatohepatitis (NASH) and primary biliary cholangitis (PBC). It also develops EDP-938, a potent N-protein inhibitor for respiratory syncytial virus; and programs to discover and develop chemical entities for the treatment of hepatitis B virus. The company also develops and markets protease inhibitor compounds for the treatment of hepatitis C virus through collaborative development and license agreement with AbbVie. Enanta is headquartered in Watertown, Massachusetts, the US.

Enanta Pharmaceuticals Inc Key Recent Developments

Feb 06,2019: Enanta Pharmaceuticals reports financial results for its fiscal first quarter and three months ended December 31, 2018
Nov 26,2018: Enanta Pharmaceuticals announces financial results for its fiscal fourth quarter and year ended September 30, 2018
Sep 05,2018: Enanta Pharmaceuticals to Present New Data on its RSV Inhibitor EDP-938 at the 11th International Respiratory Syncytial Virus Symposium[Newswire : Healthcare-BW]
Aug 07,2018: Enanta Pharmaceuticals announces financial results for its fiscal third quarter ended june 30, 2018
May 08,2018: Enanta Pharmaceuticals Reports Financial Results for Its Fiscal Second Quarter Ended March 31, 2018

This comprehensive SWOT profile of Enanta Pharmaceuticals Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Enanta Pharmaceuticals Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Enanta Pharmaceuticals Inc – Key Information
Enanta Pharmaceuticals Inc – Overview
Enanta Pharmaceuticals Inc – Key Employees
Enanta Pharmaceuticals Inc – Key Employee Biographies
Enanta Pharmaceuticals Inc – Key Operational Heads
Enanta Pharmaceuticals Inc – Major Products and Services
Enanta Pharmaceuticals Inc – History
Enanta Pharmaceuticals Inc – Company Statement
Enanta Pharmaceuticals Inc – Locations And Subsidiaries
Enanta Pharmaceuticals Inc – Key Manufacturing facilities
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Enanta Pharmaceuticals Inc – Business Description
Enanta Pharmaceuticals Inc – Corporate Strategy
Enanta Pharmaceuticals Inc – SWOT Analysis
SWOT Analysis – Overview
Enanta Pharmaceuticals Inc – Strengths
Enanta Pharmaceuticals Inc – Weaknesses
Enanta Pharmaceuticals Inc – Opportunities
Enanta Pharmaceuticals Inc – Threats
Enanta Pharmaceuticals Inc – Key Competitors

Section 3 – Company Financial Performance Charts

Enanta Pharmaceuticals Inc – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Enanta Pharmaceuticals Inc, Key Information
Enanta Pharmaceuticals Inc, Key Ratios
Enanta Pharmaceuticals Inc, Share Data
Enanta Pharmaceuticals Inc, Major Products and Services
Enanta Pharmaceuticals Inc, History
Enanta Pharmaceuticals Inc, Key Employees
Enanta Pharmaceuticals Inc, Key Employee Biographies
Enanta Pharmaceuticals Inc, Key Operational Heads
Enanta Pharmaceuticals Inc, Other Locations
Enanta Pharmaceuticals Inc, Subsidiaries
Enanta Pharmaceuticals Inc, Key Manufacturing facilities
Enanta Pharmaceuticals Inc, Key Competitors
Enanta Pharmaceuticals Inc, SWOT Analysis
Enanta Pharmaceuticals Inc, Ratios based on current share price
Enanta Pharmaceuticals Inc, Annual Ratios
Enanta Pharmaceuticals Inc, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures

Enanta Pharmaceuticals Inc, Performance Chart
Enanta Pharmaceuticals Inc, Ratio Charts

★海外企業調査レポート[Enanta Pharmaceuticals Inc (ENTA):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Martinrea International Inc.:戦略・SWOT・企業財務分析
    Martinrea International Inc. - Strategy, SWOT and Corporate Finance Report Summary Martinrea International Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Unum Therapeutics Inc (UMRX):製薬・医療:M&Aディール及び事業提携情報
    Summary Unum Therapeutics Inc (Unum Therapeutics) is a clinical-stage bio-pharmaceutical company focused on the development and commercialization of novel antibody-coupled cellular immunotherapies to fight cancers. Its pipeline product portfolio include ACTR087 + rituximab, a CD20 targeting chimeric …
  • Proteon Therapeutics Inc (PRTO):製薬・医療:M&Aディール及び事業提携情報
    Summary Proteon Therapeutics Inc (Proteon Therapeutics) is a late-stage biopharmaceutical company that develops pharmaceutical products for the treatment of renal and vascular diseases. The company develops investigational therapies to treat hemodialysis and peripheral artery disease patients. Its p …
  • Massachusetts Eye and Ear Infirmary-製薬・医療分野:企業M&A・提携分析
    Summary Massachusetts Eye and Ear Infirmary (MEE) is a healthcare service provider that offers primary, medical and surgical care services. The hospital offers services through departments such as ophthalmology, otolaryngology and patient care services. Its patient care services include patient educ …
  • Lakeview Hotel Investment Corp.:企業の戦略・SWOT・財務情報
    Lakeview Hotel Investment Corp. - Strategy, SWOT and Corporate Finance Report Summary Lakeview Hotel Investment Corp. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Australian Leaders Fund Limited:企業の戦略・SWOT・財務分析
    Australian Leaders Fund Limited - Strategy, SWOT and Corporate Finance Report Summary Australian Leaders Fund Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • BioRap Technologies Ltd-製薬・医療分野:企業M&A・提携分析
    Summary BioRap Technologies Ltd (BioRap) is a technology transfer company that offers biomedical solutions for contemporary health care industry. The company’s technologies are used in the treatment of macular disease, alopecia, cardiovascular disease, cancer and autoimmune diseases, cancer therapy, …
  • OJSC Surgutneftegas:企業の戦略・SWOT・財務分析
    OJSC Surgutneftegas - Strategy, SWOT and Corporate Finance Report Summary OJSC Surgutneftegas - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Village Roadshow Ltd:企業の戦略・SWOT・財務情報
    Village Roadshow Ltd - Strategy, SWOT and Corporate Finance Report Summary Village Roadshow Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • ConvaTec Group Plc (CTEC):医療機器:M&Aディール及び事業提携情報
    Summary ConvaTec Group Plc (ConvaTec) is a medical products and technologies company that specializes in advanced wound care, ostomy care, continence and critical care, and infusion devices. Its major products include wound dressings, skin care products, disposable infusion sets, urological catheter …
  • Obuv Rossii OOO (OBUV):企業の財務・戦略的SWOT分析
    Obuv Rossii OOO (OBUV) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Avantis Medical Systems Inc-医療機器分野:企業M&A・提携分析
    Summary Avantis Medical Systems Inc (AMS) is a medical device company that provides visualization technology solutions. The company provides products such as single camera colonoscopy devices and third eye panoramic devices. Its third eye panoramic devices provide two side-viewing cameras supplement …
  • LGC Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary LGC Ltd (LGC), formerly LGC (Teddington) Ltd is a life sciences measurement and testing company that offers reference materials, genomics solutions and analytical testing products and services. The company’s products comprise DNA extraction instrumentation, DNA extraction kits, Douglas scien …
  • The Interpublic Group of Companies, Inc. (IPG):企業の財務・戦略的SWOT分析
    The Interpublic Group of Companies, Inc. (IPG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key str …
  • Cogeco Communications Inc (CCA):企業の財務・戦略的SWOT分析
    Cogeco Communications Inc (CCA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Edwards Lifesciences Corp (EW):医療機器:M&Aディール及び事業提携情報
    Summary Edwards Lifesciences Corp (Edwards) is a medical technology company, which focuses on the development, manufacture and marketing of products and technologies to treat structural heart disease, and help provide critical care and surgical monitoring. It develops and commercializes heart valve …
  • Semperit AG Holding (SEM):企業の財務・戦略的SWOT分析
    Summary Semperit AG Holding (Semperit) is a developer, manufacturer and marketer of rubber products for the medical and industrial sectors. The company’s products include surgical gloves, examination gloves, disposable protective gloves and reusable protective gloves. It also offers hydraulic hoses, …
  • Calfrac Well Services Ltd (CFW):石油・ガス:M&Aディール及び事業提携情報
    Summary Calfrac Well Services Ltd (Calfrac) is an oilfield services company. It operates as an independent provider of specialized oilfield services. The company offers various specialized services such as hydraulic fracture-stimulation, coiled tubing, well simulation, fracturing, acidizing, frac de …
  • ElectraNet Pty Ltd:企業の戦略的SWOT分析
    ElectraNet Pty Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • Transgene SA (TNG):企業の財務・戦略的SWOT分析
    Summary Transgene SA (Transgene), a subsidiary of Institut Merieux SA, is a biotechnology company that offers discovery and development of immunotherapies in the areas of cancer and infectious diseases. The company offers products such as therapeutic vaccines and oncolytic viruses. It develops targe …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆